AstraZeneca plc (ADR) (NYSE:AZN)
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
ETMatyahoo
(52.22)
Submitted: 12/23/2011 5:43:07 PM :
Start Price:
$46.10
AZN Score:
-4.19
Note to self: "actually" in at 44.ish in this week - late Fool-tracking. Sad disclosure!
AZN's the maker of Seroquel and Mysoline, two really far out psychiatric neurological drugs. So I hear.
Recs
Recs
Recs
Chemdawg
(96.45)
Submitted: 10/8/2011 1:57:28 PM :
Start Price:
$46.91
AZN Score:
-13.64
buybacks...great yield.... 10% off 52 week low
Recs
jmt587
(99.87)
Submitted: 9/22/2011 2:10:02 PM :
Start Price:
$42.51
AZN Score:
-8.84
Long Term Outperform.
Recs
d0w0kelley
(< 20)
Submitted: 8/28/2011 12:27:40 AM :
Start Price:
$46.44
AZN Score:
-10.83
Large Cap stock trading above their 14-day SMA
Recs
STORMSTOCKER
(< 20)
Submitted: 8/11/2011 4:58:55 PM :
Start Price:
$44.79
AZN Score:
-8.19
A MAJOR DRUG COMPANY THAT HAS BEEN BEATEN DOWN.
Recs
gilboy7
(< 20)
Submitted: 8/10/2011 7:38:03 PM :
Start Price:
$41.94
AZN Score:
-6.18
Oversold on panic. New blood thinner won USDA approval last month and should lead to better profits in future reports. Great buy in price.
Recs
mrindependent
(91.56)
Submitted: 7/29/2011 5:41:11 PM :
Start Price:
$48.21
AZN Score:
-4.88
Effort to pick good longterm stocks
Recs
healthcarevalue
(96.24)
Submitted: 7/27/2011 10:15:40 AM :
Start Price:
$48.73
AZN Score:
-5.40
Debt/equity of 0.40, price/earnings of 8.67, dividend yield of 7.30%, ROIC of 25%, Pharma company based in London UK, 61,100 employees.
Recs
ipsiety
(26.58)
Submitted: 6/26/2011 7:00:38 AM :
Start Price:
$47.28
AZN Score:
-6.14
-share buyback.
-low pe
-P/S=2.1, compare that with novartis, which sits around 3.
-d/e=0.4
-12b cash vs 9.4b LT debt.
Recs
secretbonus
(33.43)
Submitted: 6/21/2011 8:48:05 PM :
Start Price:
$48.14
AZN Score:
-6.14
nice predictable business with great dividend yield at a good price
Recs
DaddioResources
(99.80)
Submitted: 6/19/2011 4:26:22 PM :
Start Price:
$48.31
AZN Score:
-8.50
There is not much more downside risk left...Per Seeking Alpha Article - The drug company is hoping for better look this time around as it seeks another FDA decision regarding its blood thinner drug, Brilinta, used for acute coronary syndrome. The FDA previously rejected the drug in December 2010. Drug reapplications do not have a good probability of success and as such the market is likely pricing in a low chance of success. If the company's luck changes this time around, it could see some stock price upside.
The stock is already cheap by most conventional metrics. It trades at a trailing P/E of 8.56, a forward P/E of 8.06 and has profit margins of nearly 25%.
Recs
mbawharton
(66.67)
Submitted: 6/3/2011 1:47:39 PM :
Start Price:
$50.38
AZN Score:
-8.82
Stock found in Graham's screener.
Recs
buyhold2
(96.77)
Submitted: 5/31/2011 5:20:29 PM :
Start Price:
$51.45
AZN Score:
-8.23
Great dividend and the cash flow to support it. Also, I think the market is inflated by the fed so time to get defensive.
Recs
Recs
RetiredAt37
(62.05)
Submitted: 4/29/2011 8:59:01 AM :
Start Price:
$48.73
AZN Score:
-1.91
Value play. The outlook for the company is not as bad as many think.
Recs
Wormis
(53.91)
Submitted: 4/23/2011 10:28:46 AM :
Start Price:
$48.96
AZN Score:
-4.19
Low P/E more cash onhand than total liabilities, and huge dividend make this stock a no brainer
Recs
Charlie1368
(< 20)
Submitted: 4/22/2011 9:19:04 PM :
Start Price:
$48.96
AZN Score:
-4.19
AztraZeneca not only pays a great yield, they also earning returns on invested capital vastly above their peers. It's cheap too, and churns out plenty of cash.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 118 : 1 2 3 4 5 6 Next »